Medtronic plc APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Medtronic plc (MDT) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $125.00 million for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-03.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-09-03
- Medtronic plc apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-07-31 was $125.00M, a 45.35% increase year-over-year.
- Medtronic plc apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-01-23 was $95.00M, a 3.06% decline year-over-year.
- Medtronic plc apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-10-24 was $182.00M, a 14.47% increase year-over-year.
- Medtronic plc apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-07-25 was $86.00M, a 3.61% increase year-over-year.
- Medtronic plc apic, share-based payment arrangement, increase for cost recognition for fiscal 2026 was $457.00M, a 6.53% increase from fiscal 2025.
- Medtronic plc apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $429.00M, a 9.16% increase from fiscal 2024.
- Medtronic plc apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $393.00M, a 10.70% increase from fiscal 2023.
- Medtronic plc apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $355.00M, a 1.11% decline from fiscal 2022.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-07-31 | $125.00M 10-Q · filed 2026-09-03 | |||
| 2026-04-24 | $457.00M 10-K · filed 2026-06-18 | |||
| 2026-01-23 | $95.00M 10-Q · filed 2026-02-24 | $277.00M derived: sum of 2 quarters · filed 2026-02-24 | $363.00M derived: sum of 3 quarters · filed 2026-09-03 | |
| 2025-10-24 | $182.00M 10-Q · filed 2026-02-24 | $268.00M derived: sum of 2 quarters · filed 2026-09-03 | ||
| 2025-07-25 | $86.00M 10-Q · filed 2026-09-03 | |||
| 2025-04-25 | $429.00M 10-K · filed 2026-06-18 | |||
| 2025-01-24 | $98.00M 10-Q · filed 2026-02-24 | $257.00M derived: sum of 2 quarters · filed 2026-02-24 | $340.00M derived: sum of 3 quarters · filed 2026-02-24 | |
| 2024-10-25 | $159.00M 10-Q · filed 2026-02-24 | $242.00M derived: sum of 2 quarters · filed 2026-02-24 | ||
| 2024-07-26 | $83.00M 10-Q · filed 2026-02-24 | |||
| 2024-04-26 | $393.00M 10-K · filed 2026-06-18 | |||
| 2024-01-26 | $85.00M 10-Q · filed 2025-02-25 | $231.00M derived: sum of 2 quarters · filed 2025-02-25 | $304.00M derived: sum of 3 quarters · filed 2025-02-25 | |
| 2023-10-27 | $146.00M 10-Q · filed 2025-02-25 | $219.00M derived: sum of 2 quarters · filed 2025-02-25 | ||
| 2023-07-28 | $73.00M 10-Q · filed 2025-02-25 | |||
| 2023-04-28 | $355.00M 10-K · filed 2025-06-20 | |||
| 2023-01-27 | $81.00M 10-Q · filed 2024-02-27 | $218.00M derived: sum of 2 quarters · filed 2024-02-27 | $280.00M derived: sum of 3 quarters · filed 2024-02-27 | |
| 2022-10-28 | $137.00M 10-Q · filed 2024-02-27 | $199.00M derived: sum of 2 quarters · filed 2024-02-27 | ||
| 2022-07-29 | $62.00M 10-Q · filed 2024-02-27 | |||
| 2022-04-29 | $359.00M 10-K · filed 2024-06-20 | |||
| 2022-01-28 | $78.00M 10-Q · filed 2023-03-01 | $218.00M derived: sum of 2 quarters · filed 2023-03-01 | $287.00M derived: sum of 3 quarters · filed 2023-03-01 | |
| 2021-10-29 | $140.00M 10-Q · filed 2023-03-01 | $209.00M derived: sum of 2 quarters · filed 2023-03-01 | ||
| 2021-07-30 | $69.00M 10-Q · filed 2023-03-01 | |||
| 2021-04-30 | $344.00M 10-K · filed 2023-06-22 | |||
| 2021-01-29 | $65.00M 10-Q · filed 2022-03-03 | $205.00M derived: sum of 2 quarters · filed 2022-03-03 | $275.00M derived: sum of 3 quarters · filed 2022-03-03 | |
| 2020-10-30 | $140.00M 10-Q · filed 2022-03-03 | $210.00M derived: sum of 2 quarters · filed 2022-03-03 | ||
| 2020-07-31 | $70.00M 10-Q · filed 2022-03-03 | |||
| 2020-04-24 | $297.00M 10-K · filed 2022-06-23 | |||
| 2020-01-24 | $66.00M 10-Q · filed 2021-03-05 | $174.00M derived: sum of 2 quarters · filed 2021-03-05 | $235.00M derived: sum of 3 quarters · filed 2021-03-05 | $297.00M derived: sum of 4 quarters · filed 2021-06-25 |
| 2019-10-25 | $108.00M 10-Q · filed 2021-03-05 | $169.00M derived: sum of 2 quarters · filed 2021-03-05 | $231.00M derived: sum of 3 quarters · filed 2021-06-25 | $291.00M derived: sum of 4 quarters · filed 2021-06-25 |
| 2019-07-26 | $61.00M 10-Q · filed 2021-03-05 | $123.00M derived: sum of 2 quarters · filed 2021-06-25 | $183.00M derived: sum of 3 quarters · filed 2021-06-25 | $287.00M derived: sum of 4 quarters · filed 2021-06-25 |
| 2019-04-26 | $62.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-25 | $122.00M derived: sum of 2 quarters · filed 2021-06-25 | $226.00M derived: sum of 3 quarters · filed 2021-06-25 | $290.00M 10-K · filed 2021-06-25 |
| 2019-01-25 | $60.00M 10-Q · filed 2020-02-28 | $164.00M derived: sum of 2 quarters · filed 2020-02-28 | $228.00M 10-Q · filed 2019-03-01 | $302.00M derived: sum of 4 quarters · filed 2020-06-19 |
| 2018-10-26 | $104.00M 10-Q · filed 2020-02-28 | $168.00M 10-Q · filed 2018-11-29 | $242.00M derived: sum of 3 quarters · filed 2020-06-19 | $314.00M derived: sum of 4 quarters · filed 2020-06-19 |
| 2018-07-27 | $64.00M 10-Q · filed 2020-02-28 | $138.00M derived: sum of 2 quarters · filed 2020-06-19 | $210.00M derived: sum of 3 quarters · filed 2020-06-19 | $316.00M derived: sum of 4 quarters · filed 2020-06-19 |
| 2018-04-27 | $74.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-19 | $146.00M derived: sum of 2 quarters · filed 2020-06-19 | $252.00M derived: sum of 3 quarters · filed 2020-06-19 | $344.00M 10-K · filed 2020-06-19 |
| 2018-01-26 | $72.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-01 | $178.00M derived: sum of 2 quarters · filed 2019-03-01 | $270.00M 10-Q · filed 2019-03-01 | $346.00M derived: sum of 4 quarters · filed 2019-06-21 |
| 2017-10-27 | $106.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-11-29 | $198.00M 10-Q · filed 2018-11-29 | $274.00M derived: sum of 3 quarters · filed 2019-06-21 | $356.00M derived: sum of 4 quarters · filed 2019-06-21 |
| 2017-07-28 | $92.00M 10-Q · filed 2018-08-31 | $168.00M derived: sum of 2 quarters · filed 2019-06-21 | $250.00M derived: sum of 3 quarters · filed 2019-06-21 | $361.00M derived: sum of 4 quarters · filed 2019-06-21 |
| 2017-04-28 | $76.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-21 | $158.00M derived: sum of 2 quarters · filed 2019-06-21 | $269.00M derived: sum of 3 quarters · filed 2019-06-21 | $348.00M 10-K · filed 2019-06-21 |
| 2017-01-27 | $82.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-02 | $193.00M derived: sum of 2 quarters · filed 2018-03-02 | $272.00M 10-Q · filed 2018-03-02 | |
| 2016-10-28 | $111.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-12-04 | $190.00M 10-Q · filed 2017-12-04 | ||
| 2016-07-29 | $79.00M 10-Q · filed 2016-09-07 | |||
| 2016-04-29 | $375.00M 10-K · filed 2018-06-22 | |||
| 2015-04-24 | $439.00M 10-K · filed 2017-06-27 | |||
| 2014-04-25 | $145.00M 10-K · filed 2016-06-28 | |||
| 2013-04-26 | $152.00M 10-K · filed 2015-06-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B |